LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

ANA Investigates: The Future of Biomarkers in Alzheimer Disease

Photo from wikipedia

T he most common cause of dementia in older adults is Alzheimer disease (AD), a speci fi c neurodegenerative disease that is de fi ned by the presence of amyloid… Click to show full abstract

T he most common cause of dementia in older adults is Alzheimer disease (AD), a speci fi c neurodegenerative disease that is de fi ned by the presence of amyloid plaques and tau tangles in the brain. Although, for many years, an autopsy was required to de fi nitively diagnose AD, this has changed with the development of AD biomarkers that re fl ect AD brain pathology. Amyloid and tau positron emission tomography (PET), and cerebrospinal fl uid (CSF) levels of amyloid- β 42 (A β 42), total tau, and tau phosphorylated at position 181, are highly correlated with AD brain pathology. These biomarkers are now widely used in research and clinical trials. Appropriate use criteria for amyloid PET and CSF 4

Keywords: investigates future; disease; alzheimer disease; future biomarkers; pathology; ana investigates

Journal Title: Annals of Neurology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.